Kahe, Ka
- Columbia University · Obstetrics & Gynecology (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #1,820
- Rising Star
- R01 Holder
- Long-Funded
- Top 10% Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2008 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Obstetrics & Gynecology
NIH Funding · FY2023
Linked Award Amount
$3M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#1,820
By linked amount among FY2023 PIs
Earliest Year Loaded
2008
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Kahe, Ka as a PI. Multi-PI records show the full award amount for context.
- 1RF1AG077255-01A1RF1Contact PIRadon exposure in relation to the risk of cognitive impairment and mitochondrial functionColumbia University · Obstetrics & Gynecology (NIH department code)$2.4Maward amount
- 5R01NS122449-03R01Contact PIResidential Radon Exposure and Stroke Risk: the REGARDS StudyColumbia University · Obstetrics & Gynecology (NIH department code)$612.6Kaward amount
Award organization
Organizations that administered FY2023 awards listing Kahe, Ka as a PI.
FY2023 award administered by Columbia University (NY).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2008First NIH AwardColumbia University
- 2008$500K Cumulative Funding
- 2012$1M Cumulative Funding
- 2012R01 Grant Holder
- 2014$2M Cumulative Funding
- 2017$5M Cumulative Funding
- 2017Entered Top 50% NationallyRanked #1287
- 2017Entered Top 25% NationallyRanked #1287
- 2017Entered Top 10% NationallyRanked #1287
- 2023$10M Cumulative Funding